Cargando…
Antibodies to the N-Terminal Domain of Angiotensin-Converting Enzyme (ACE2) That Block Its Interaction with SARS-CoV-2 S Protein
SARS-CoV-2 is a new coronavirus that is the cause of COVID-19 pandemic. To enter the cell, the virus interacts via its surface S protein with angiotensin-converting enzyme 2 (ACE2), the main entry receptor on the cell membrane. Most of protective antibodies, including those induced by vaccinations,...
Autores principales: | Krut, V. G., Astrakhantseva, I. V., Chuvpilo, S. A., Efimov, G. A., Ambaryan, S. G., Drutskaya, M. S., Nedospasov, S. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649309/ https://www.ncbi.nlm.nih.gov/pubmed/34874527 http://dx.doi.org/10.1134/S160767292201001X |
Ejemplares similares
-
Will Peptides Help to Stop COVID-19?
por: Krut’, Viktoriya G., et al.
Publicado: (2022) -
SARS-CoV-2 Binding and Neutralization Properties of Peptides Derived from N-Terminus of Human ACE2
por: Astrakhantseva, Irina V., et al.
Publicado: (2023) -
On Immunological Studies at Sirius University of Science and Technology
por: Astrakhantseva, I. V., et al.
Publicado: (2023) -
Properties and Activity of Peptide Derivatives of ACE2 Cellular Receptor and Their Interaction with SARS-CoV-2 S Protein Receptor-Binding Domain
por: Sidorova, M. V., et al.
Publicado: (2022) -
Regulation of the Placental Renin-Angiotensin-Aldosterone System in Early- and Late-Onset Preeclampsia
por: Artemieva, K. A., et al.
Publicado: (2022)